A spontaneous hematoma reminds columnist Jennifer Lynne of the importance of taking all symptoms and bleeding seriously with hemophilia.

Cutting-edge DNA mapping technology has identified new genetic information that can help researchers decipher more genetic ...

The UK medicines regulator has approved Pfizer’s marstacimab for patients aged 12 years or older with severe haemophilia A or B, offering a new subcutaneous treatment option.

Researchers from the Francis Crick Institute, UCL, Gustave Roussy and Memorial Sloan Kettering Cancer Center (MSK), have ...

Pfizer’s Hympavzi (marstacimab) has been approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to ...

DelveInsight's "HEMLIBRA Market Size, Forecast, and Market Insight Report" highlights the details around HEMLIBRA, a ...

Many people in Kenya may be living with an undiagnosed rare bleeding disorder known as hemophilia, which may put them at risk ...

Research marks one of the longest gene therapy study follow-ups to date PHILADELPHIA, April 17, 2025 /PRNewswire/ -- Researchers at Children's Hospital of Philadelphia (CHOP) in collaboration with ...

The provision of medical care to hemophiliacs is in the hands of health professionals at the Institute of Hematology and ...

Genetic mutation causing hemophilia in European monarchies, underdiagnosed in India, requires improved treatment and ...

Hemophilia is a genetic condition where the body doesn't produce enough of the clotting factors needed to stop bleeding. Know ...

This World Hemophilia Day, global focus shifts to the often-overlooked struggles of women with haemophilia, calling for ...